Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Michael

Showing results (171-180 of 216) with videos related to

Pageof 22
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 25, 2011
Twenty-five-year experience with radical chemoradiation for anal cancerJonathan M Tomaszewski, Emma Link, Trevor Leong, et al.
Acta Oncologica (Stockholm, Sweden)|August 16, 2022
Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trialSarah Glewis, Marliese Alexander, Senthil Lingaratnam, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 12, 2022
Diagnostic performance of positron emission tomography in the staging of pseudomyxoma peritoneiMichael P Flood, Joseph C Kong, Toan Pham, et al.
Endocrine-Related Cancer|May 27, 2025
Peptide receptor radionuclide therapy in malignant insulinomaDavid A Pattison, Grace Kong, Timothy Akhurst, et al.
Microbial Genomics|October 28, 2025
An integrated multi-omic approach for discovery and dereplication of bioactive microbial natural productsNegero Gemeda Negeri, Duong Duc Anh Nguyen, Michael Michael, et al.
JAMA Oncology|September 21, 2023
Risk-Directed Ambulatory Thromboprophylaxis in Lung and Gastrointestinal Cancers: The TARGET-TP Randomized Clinical TrialMarliese Alexander, Sam Harris, Craig Underhill, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 4, 2007
Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseasesDetlef Zillikens, Kurt Derfler, Rüdiger Eming, et al.
Clinical and Translational Science|November 29, 2024
Pharmacogenetic-guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC-PGx): A multicenter clinical trialSarah Glewis, Senthil Lingaratnam, Benjamin Lee, et al.
Cancer Chemotherapy and Pharmacology|March 23, 2021
Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR studyMichael Michael, Winston Liauw, Sue-Anne McLachlan, et al.
Annals of Medicine and Surgery (2012)|June 8, 2026
Predicting recurrence patterns and outcomes following resection of pancreatic ductal adenocarcinoma: a contemporary real-world data cohort studyEden Mane, Mark Tacey, Ben Loveday, et al.
Pageof 22

Showing results (171-180 of 216) with videos related to

Sort By:
Pageof 22
International Journal of Radiation Oncology, Biology, Physics|October 25, 2011
Twenty-five-year experience with radical chemoradiation for anal cancerJonathan M Tomaszewski, Emma Link, Trevor Leong, et al.
Acta Oncologica (Stockholm, Sweden)|August 16, 2022
Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trialSarah Glewis, Marliese Alexander, Senthil Lingaratnam, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 12, 2022
Diagnostic performance of positron emission tomography in the staging of pseudomyxoma peritoneiMichael P Flood, Joseph C Kong, Toan Pham, et al.
Endocrine-Related Cancer|May 27, 2025
Peptide receptor radionuclide therapy in malignant insulinomaDavid A Pattison, Grace Kong, Timothy Akhurst, et al.
Microbial Genomics|October 28, 2025
An integrated multi-omic approach for discovery and dereplication of bioactive microbial natural productsNegero Gemeda Negeri, Duong Duc Anh Nguyen, Michael Michael, et al.
JAMA Oncology|September 21, 2023
Risk-Directed Ambulatory Thromboprophylaxis in Lung and Gastrointestinal Cancers: The TARGET-TP Randomized Clinical TrialMarliese Alexander, Sam Harris, Craig Underhill, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 4, 2007
Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseasesDetlef Zillikens, Kurt Derfler, Rüdiger Eming, et al.
Clinical and Translational Science|November 29, 2024
Pharmacogenetic-guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC-PGx): A multicenter clinical trialSarah Glewis, Senthil Lingaratnam, Benjamin Lee, et al.
Cancer Chemotherapy and Pharmacology|March 23, 2021
Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR studyMichael Michael, Winston Liauw, Sue-Anne McLachlan, et al.
Annals of Medicine and Surgery (2012)|June 8, 2026
Predicting recurrence patterns and outcomes following resection of pancreatic ductal adenocarcinoma: a contemporary real-world data cohort studyEden Mane, Mark Tacey, Ben Loveday, et al.
Pageof 22